BROWSE BY TOPIC
Stories of Interest
- Goldman's Lloyd Blankfein Seems to be Making a Habit Out of Trolling Trump
- Goldman on Hunt for Star Traders to Revive Struggling Commodities Unit
- Yahoo Owes Millions for Busting NCAA Tourney Bracket Deal
- JPMorgan Joins 21st Century Fox in Fighting 'Deep Divisions Across Our Country'
- Please, God, Save Gary Cohn From Himself: The Case for Resigning
- Regulatory Considerations When Bringing on a New Advisor
- Why Deutsche Bank is at Mercy of Regulators
- U.S. Treasury Auction Class-Action – Federal Judge Causes Interminable Delay
- Mnuchin Rejects Calls to Resign and Defends Trump
- Best Time to Go to the U.S. (Tennis) Open Tourney - Before It Starts on August 28
- Stifel Prevails in Arbitration But Ex-Hilltop Employees Hit with Awards - Bill Singer
- Banca IMI Securities to Pay $35Mn for Improper Handling of ADRs in Continuing SEC Crackdown
- Members of White House ‘Arts Panel’ Resign En Masse in Protest of Trump
- FINRA Whiffs on Disciplinary Sanction: Bill Singer's 'Negligent Market Manipulation in OTC Stock Promotion'
- Heather Heyer’s Mother Says, ‘I’m Not Talking to the President’
- Goldman Sachs May Have Lost $100Mn on Energy Bet Gone Wrong
- SEC Drops Case Against Ex-JPMorgan Traders Over 'London Whale'
- Financial Advisers That Invest in Technology Need to Accomplish These Two Things
- FINRA Amends Codes Regarding Expedited Arbitrator List Selection
- FINRA July 2017 Quarterly Disciplinary Review (Podcast)
We seek to provide information, insights and direction that may enable the Financial Community to effectively and efficiently operate in a regulatory risk-free environment by curating content from all over the web.
Stay Informed with the latest fanancialish news.
NEWSLETTERS & ALERTS
'Pharma Bro' Martin Shkreli Guilty of Securities Fraud
[Photo: Screen Grab from CBS News]
A federal jury found Martin Shkreli - aka 'Pharm Bro' - guilty on 3 counts of securities fraud, but acquitted him on 5 other counts. He faces up to 20 years in prison on the most serious charges, though he's likely to get much less.
Shkreli was charged with 8 separate counts of securities fraud, conspiracy to commit securities fraud and wire fraud, for his role managing a pair of hedge funds - MSMB Capital Management and MSMB Healthcare - between 2009 and 2014.
The government had accused Shkreli of defrauding investors and lying about the funds' performance, and that he later stole more than $11 million from Retrophin, a company he founded and brought public, to pay back those investors. However, the case was tricky for prosecutors because investors, some wealthy financiers from Texas, condeded at the trial that Shkreli's scheme actually made them richer, in some cases doubling or even tripling their money on his company's stock when it went public. The defense portrayed them as spoiled "rich people" who were the ones doing the manipulating.
"Who lost anything? Nobody," defense attorney Brafman said in his closing argument. Some investors had to admit on the witness stand that partnering with Shkreli was "the greatest investment I've ever made," he added.
Federal prosecutors responded: “Just because the defendant got lucky and Retrophin became a success years later” that doesn’t excuse fraud. “Martin Shkreli doesn’t think the rules doesn’t apply to him, that the law doesn’t apply to him unfortunately for him, it does.”
Shkreli and his lawyer, Ben Brafman, were thrilled by the verdict. "We think verdict as it now stands, will permit this court to impose very lenient sentence," Brafman said - which Shkreli interpreted to mean that he may serve only a couple of months in "Club Fed."